Prognostic Factors in Treatment of Depressive States with Imipramine.
作者信息
Kiloh L G, Ball J R, Garside R F
出版信息
Br Med J. 1962 May 5;1(5287):1225-7. doi: 10.1136/bmj.1.5287.1225.
Abstract
摘要
相似文献
1
Prognostic Factors in Treatment of Depressive States with Imipramine.
Br Med J. 1962 May 5;1(5287):1225-7. doi: 10.1136/bmj.1.5287.1225.
2
Influence of imipramine on the circulatory system in the course of endogenous depressive syndromes. I. Evaluation of the basic parameters of the circulatory system.
Arch Immunol Ther Exp (Warsz). 1975;23(6):795-801.
3
[Imipramine hydrochloride in the treatment of depressive states].
Dia Med. 1960 May 5;32:806-9.
4
The treatment of depressive states with particular reference to imipramine.
Practitioner. 1960 May;184:652-61.
5
Tofranil (imipramine) in the treatment of depressive states.
J Nerv Ment Dis. 1960 Feb;130:146-50. doi: 10.1097/00005053-196002000-00007.
6
A controlled trial of imipramine in treatment of depressive states.
Br Med J. 1959 Nov 21;2(5159):1052-5. doi: 10.1136/bmj.2.5159.1052.
7
A controlled trial of imipramine ("Tofranil") in the treatment of severe depressive states.
J Ment Sci. 1961 May;107:552-9. doi: 10.1192/bjp.107.448.552.
8
The treatment of depressive states with G 22355 (imipramine hydrochloride).
Am J Psychiatry. 1958 Nov;115(5):459-64. doi: 10.1176/ajp.115.5.459.
9
The treatment of depressive states with imipramine hydrochloride (tofranil).
J Ment Sci. 1959 Oct;105:1123-6. doi: 10.1192/bjp.105.441.1123.
10
Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):57-65. doi: 10.1016/S0278-5846(03)00177-5.
引用本文的文献
1
To-day's Drugs.
Br Med J. 1963 Jan 19;1(5324):173-5.
2
THE PHARMACOTHERAPY OF THE DEPRESSIVE SYNDROME.
Can Med Assoc J. 1965 Apr 10;92(15):821-8.
3
MODES OF ONSET OF PSYCHOTIC DEPRESSION.
Br Med J. 1964 Sep 26;2(5412):779-84. doi: 10.1136/bmj.2.5412.779.
4
[ON THE METHODOLOGY OF RESEARCH ON ANTIDEPRESSIVE DRUGS WITH SPECIAL REFERENCE TO IMIPRAMINE (TOFRANIL) AND DESMETHYLIMIPRAMINE (PERTOFRAN)].
Arch Psychiatr Nervenkr. 1963 Sep 18;204:427-45.
5
Prediction of short-term outcome of neurotic-depressive inpatients. Results of an empirical study of 134 inpatients.
Eur Arch Psychiatry Clin Neurosci. 1993;242(5):301-9. doi: 10.1007/BF02190390.
6
A statistical model for the classification of imipramine response in depressed inpatients.
Psychopharmacology (Berl). 1982;78(2):185-9. doi: 10.1007/BF00432260.
7
Observations on some diurnal rhythms in depressive illness.
Br Med J. 1966 Dec 31;2(5530):1620-3. doi: 10.1136/bmj.2.5530.1620.
8
Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive inpatients.
Eur Arch Psychiatry Neurol Sci. 1987;236(6):349-57. doi: 10.1007/BF00377424.
9
The prediction of recovery using a multivariate model in 1471 depressed inpatients.
Eur Arch Psychiatry Clin Neurosci. 1991;241(1):41-5. doi: 10.1007/BF02193753.
10
The comparative value of types of rating scale.
Br J Clin Pharmacol. 1976 Feb;3(1 Suppl 1):61-7. doi: 10.1111/j.1365-2125.1976.tb03715.x.
本文引用的文献
1
A controlled trial of imipramine in treatment of depressive states.
Br Med J. 1959 Nov 21;2(5159):1052-5. doi: 10.1136/bmj.2.5159.1052.
2
Depression treated with imipramine: a follow-up study.
Br Med J. 1961 Jan 21;1(5220):168-71. doi: 10.1136/bmj.1.5220.168.
3
Factors related to the outcome of depression treated with E.C.T.
J Ment Sci. 1960 Jul;106:1031-41. doi: 10.1192/bjp.106.444.1031.
4
Depressive states: their aetiology and treatment.
Br Med J. 1958 Aug 9;2(5092):341-4. doi: 10.1136/bmj.2.5092.341.
Zotero 插件